A Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Diabetic Patients.

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 558 participants.

Also called NCT02156349

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 558 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02156349
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02156349. Randomized; no masking; primary purpose diagnostic. Start 2014-05-14 (actual); primary completion 2017-04-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Diabetic Patients.
Acronym
PDMProValueDSP
Condition
Type II Diabetes Mellitus
Intervention (Device)
Accu-Chek Smart Pix Software
Intervention (Device)
Accu-Chek Smart Pix readout Device
Lead sponsor
Hoffmann-La Roche (class: industry)
Collaborator
Roche Diabetes Care (class: industry)

Record details

Record id
cardio:ct-nct02156349
Content hash
497e5631efce3d5418c7346bc32bc30e95270a6d757d2501c95355e3d482cc05